Comparison of endoscopic papillary balloon dilatation and endoscopic sphincterotomy for bile duct stones

Table 1 Short term treatment results of endoscopic papillary balloon dilatation and endoscopic sphincterotomy

Ref.	Sample size (EPBD/EST)	Indication	Complete stone removal	Early procedural accident (whole)	Pancreatitis	Mild	Moderate	Severe	Cholecystitis	Cholangitis	Bleeding	Perforation	Basket impaction
Minami et al[11]	20/20	No limit	100% /100%	10% /10%	10%/10%	-	-	-	-	-	-	-	-
Bergman et al[12]	101/101	No limit	89%/91%	17% /24%	6.9%/6.9%	-	-	-	-	-	0%/4.0%	2.0%/1.0%	-
Ochi et al[13]	55/55	Diameter < 15 mm, number < 10	98.1%/92.7%	2.0%/5.6%	0%/3.7%	0%/0%	0%/3.7%	0%/0%	-	-	-	0%/1.9%	-
Yasuda et al[14]	35/35	No limit	100%/100%	5.7% /8.6%	5.7%/5.7%	5.7%/5.7%	0%/0%	0%/0%	-	-	0%/2.9%	-	-
Arnold et al[15]	30/30	Diameter < 20 mm, number < 5	77%/100%1	30.0%/16.7%	20%/10%	13.3%/10%	0%/0%	6.7%/0%	-	10%/0%	0%/6.7%	-	-
Natsui et al[16]	70/70	No limit	92.9%/98.6%	10.0%/11.4%	5.7%/4.3%	5.7%/4.3%	-	-	-	2.9%/4.3%	0%/2.9%	-	1.4%/0%
Vlavianos et al[17]	103/99	No limit	87.4%/86.9%	6.8%/3.0%	4.9%/1.0%	1.9%/0%	1.9%/1.0%	1.0%/0%	-	1.9%/1.0%	-	-	-
Fujita et al[18]	138/144	Diameter < 14 mm	99.3%/100%	14.5%/11.8%	10.9%/2.8%1	8.7%/2.1%	2.2%/0.7%	9%/0%	2.2%/4.2%	1.4%/4.2%	0%/1.4%	-	0.7%/0.7%
Baron et al[19]	552/554	Meta-analysis	94%/96%	10.4%/10.3%	7.4%/4.3%1	-	-	-	2.7%/3.6%	-	0%/2.0%1	0.4%/0.4%	-
Disario et al[20]	117/120	Diameter < 10 mm, number < 4	97.4%/92.5%	17.9%/3.3%1	10.3%/0.8%1	-	-	5.1%/0%	0%/0.8%	0.9%/0.8%	10.5%/27.0%1	0%/0.8%	-
Lin et al[21]	51/ 53	Diameter < 20 mm	94.1% /100%	-	-	-	-	-	-	-	2.0%26.4%1	0%/0.8%	-
Takezawa et al[22]	46/45	No limit	100%/100%	0%/0%	-	-	-	-	-	-	-	-	-
Tanaka et al[23]	16/16	No limit	100%/100%	18.8%/25.0%	18.8%/18.8%	-	-	-	-	0%/12.5%	-	-	-
Watanabe et al[24]	90/90	No limit	86.6%/95.6%	14.4%/3.3%1	10.0%/2.2%1	8.9%/0%	1.1%/2.2%	-	-	3.3%/0%	1.1%/0%		1.1%/0%

¹P < 0.05. EPBD: Endoscopic papillary balloon dilatation; EST: Endoscopic sphincterotomy.

Table 2 Comparison of long term prognosis between endoscopic papillary balloon dilatation and endoscopic sphincterotomy

Ref.	Sample size (EPBD/EST)	Follow-up period	Total	Stone recurrence	Cholangitis	Cholecystitis	Liver abscess	Biliary cancer
Bergman et al[12]	101/101	6 mo	18%/23%	7.9%/6.9%	-	1.3%/9.9%	0%/1.0%	-
Ochi et al[13]	51/54	Median 23 mo	3.9%/14.8%	3.9%/5.6%	3.9%/3.7%	3.3%/18.5%	-	-
Yasuda et al[14]	235/126	Median 37.4/36.3 mo	-	10%/14%	0%/3.2%	2.0%/8.8%	-	-
Natsui et al[16]	68/69	Median 30 mo	5.9%/8.7%	4.4%/4.3%	-	3.6%/7.9%	-	-
Vlavianos et al[17]	103 /99	12 mo	11.7%/15.2%	1.9%/3.0%	1.9%/1.0%	1.9%/2.0%	-	-
Lin et al[21]	51/53	Median 16 mo	-	5.9%/7.5%	-	-	-	-
Yasuda et al[51]	138 /144	Median 6.7 yr	10.1%/25.0%1	7.8%/17.4%1	0%/2.8%	5.5%/8.3%	0%/1.4%	0%/0.7%

¹P < 0.05. EPBD: Endoscopic papillary balloon dilatation; EST: Endoscopic sphincterotomy.